Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).
Saved in:
| Title: | Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study). |
|---|---|
| Authors: | Nagai SE; Division of Breast Oncology, Saitama Prefectural Cancer Center, Saitama, Japan., Hattori M; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan., Yoshinami T; Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan., Masuda H; Department of Breast Surgical Oncology, School of Medicine, Showa University, Tokyo, Japan., Okamura T; Department of Breast Oncology, Tokai University School of Medicine, Tokyo, Japan., Watanabe K; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan., Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan., Takabatake D; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Harao M; Department of Breast Oncology, Jichi Medical University, Shimotsuke, Japan., Yoshino H; Breast and Endocrinological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan., Mori N; Department of Breast Surgery, Seirei Hamamatsu General Hospital, Hamamatsu, Japan., Yasojima H; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Oshiro C; Department of Breast Surgery, Kaizuka City Hospital, Osaka, Japan., Iwase M; Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan., Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan., Sangai T; Department of Breast and Thyroid Surgery, Kitasato University School of Medicine, Sagamihara, Japan., Sasada S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Ishida T; Division of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Tokyo, Japan., Futamura M; Department of Breast Surgery, Gifu University Hospital, Gifu, Japan., Muramatsu Y; Oncology Medical Affairs, Pfizer Japan Inc, Tokyo, Japan., Kosaka N; Oncology Medical Affairs, Pfizer Japan Inc, Tokyo, Japan., Masuda N; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan. nmasuda@alpha.ocn.ne.jp. |
| Source: | Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Jul; Vol. 32 (4), pp. 705-715. Date of Electronic Publication: 2025 Apr 05. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1880-4233 |
|---|---|
| DOI: | 10.1007/s12282-025-01689-4 |
